Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 8/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.46 |
| ▸ | ACSL1 | P33121 | 1/20 | 0.45 |
| ▸ | CDK4 | P11802 | 1/20 | 0.45 |
| ▸ | CCND1 | P24385 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | SLC5A7 | Q9GZV3 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | F10 | P00742 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10185608 | 0.93 | SMN1; SMN2 (0.57) | HPGDKDM4EALDH1A1SMN1; SMN2CDK4 | |
| SCHEMBL10184493 | 0.93 | DGAT1 (0.47) | DGAT1HPGDKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL10184323 | 0.91 | DGAT1 (0.56) | DGAT1HPGDALDH1A1HSD17B10MEN1 | |
| SCHEMBL664114 | 0.91 | DGAT1 (0.56) | DGAT1HPGDALDH1A1HSD17B10MEN1 | |
| SCHEMBL664113 | 0.91 | DGAT1 (0.56) | DGAT1HPGDALDH1A1HSD17B10MEN1 | |
| SCHEMBL10186059 | 0.89 | KDM4E (0.46) | DGAT1HPGDKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL10186147 | 0.88 | NPC1 (0.54) | DGAT1SLC5A7MEN1KMT2AF10 | |
| SCHEMBL10184403 | 0.87 | DGAT1 (0.54) | DGAT1KDM4EALDH1A1EPHX2HSD17B10 | |
| SCHEMBL10185204 | 0.87 | ACSL1 (0.49) | DGAT1SMN1; SMN2ACSL1MEN1KMT2A | |
| SCHEMBL10186131 | 0.87 | NPC1 (0.49) | DGAT1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120046292-A1 | DIACYLETHYLENEDIAMINE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2012-02-23 | — | — | US | disclosed |
| WO-2010122968-A1 | DIACYLETHYLENEDIAMINE COMPOUND | アステラス製薬株式会社 (JP) | 2010-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046292-A1 | DIACYLETHYLENEDIAMINE COMPOUND | DGAT1, DGAT2, DIMT1 | DGAT1 1/4885HPGD 3492/4885KDM4E 3060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.